数字互动干预对前列腺癌生存结果的影响:系统叙事审查
Maryam Maleki1, Abbas Mardani2, Negar Sadeghi3
1Social Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
BMC cancer
|December 22, 2025
概括
数字干预改善了前列腺癌幸存者的尿路症状和生活质量. 然而,对性和肠道问题的影响仍然不一致,需要进一步研究以获得最佳支持.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 前列腺癌 (PCa) 是一种普遍存在的男性恶性瘤,具有显著的长期生存挑战.
- 数字干预为PCa生存提供了可扩展的解决方案,但其有效性尚未得到一致确立.
- 本综述综合了针对PCa幸存者结果的数字交互干预的证据.
研究的目的:
- 系统地审查和描述数字交互干预对前列腺癌幸存者的生存结果的有效性.
- 确定特定的数字干预类型及其对各种PCa幸存者领域的影响.
主要方法:
- 按照PRISMA指南进行系统叙事审查.
- 搜索了主要的数据库 (Web of Science,PubMed,Scopus,Embase,CINAHL) 的英语干预研究.
- 使用PICOS框架进行研究选择;使用RoB 2,ROBINS-I和NIH工具评估偏差风险;由于异质性而进行叙事综合.
主要成果:
- 24项研究 (2012-2024) 使用了各种数字干预措施 (基于网络,应用程序,远程医疗,物联网,在线教育).
- 观察到尿路症状 (持续长达12个月),生活质量,心理健康,自我效能和身体活动的持续改善.
- 对性功能有不同的结果;对荷尔蒙和肠道症状的益处有限;对睡眠和疲劳的影响不一致.
结论:
- 数字干预有效地提高了PCa幸存者的尿功能,生活质量,心理健康和自我效能,特别是多组件,定制的方法.
- 对性,激素和肠道症状的影响不一致,表明需要进一步调查.
- 标准化结果,进行长期试验和开发混合数字-人际关系模型对于优化PCa幸存者护理和访问至关重要.
相关概念视频
01:21Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K